HealthJun 9, 2026Dapagliflozin Lowers Heart-Failure Risk in Genetic GroupResearchers performed an analysis of the DECLARE-TIMI 58 randomized trial dataset (more than 12,000 adults with type 2 diabetes and elevated cardiovascular risk) to ...Cardiac HealthSGLT2 inhibitors (dapagliflozin)
